首页> 外国专利> 2,2'-BI-1H-PYRROLE DERIVATIVES USEFUL IN THE TREATMENT OF LEUKEMIA BROUGHT ON BY HTLV-I

2,2'-BI-1H-PYRROLE DERIVATIVES USEFUL IN THE TREATMENT OF LEUKEMIA BROUGHT ON BY HTLV-I

机译:2,2'-BI-1H-吡咯衍生物可用于HTLV-I治疗白血病引起的白血病

摘要

The use of a compound which is a 2,2'-bi-1H-pyrrole of formula (I) wherein R1 is hydrogen, phenyl, C1-C20 alkyl or C2-C20 alkenyl, wherein the alkyl and alkenyl groups are unsubstituted or substituted by 1 to 3 substituents; R2 is hydrogen, C1-C6 alkyl, cyano, carboxy or (C1-C6 alkoxy)carbonyl; R3 is halogen, hydroxy or C1-C11 alkoxy unsubstituted or substituted by phenyl; R4 represent hydrogen, C1-C6 alkyl or phenyl; each of R5 and R6, which are the same or different, independently represents hydrogen, C2-C20 alkanoyl, C3-C20 alkenoyl, phenyl, C1-C20 alkyl or C2-C20 alkenyl, wherein the alkanoyl, alkenoyl, alkyl and the alkenyl groups are unsubstituted or substituted by 1 to 3 substituents; or two of R4, R5 and R6 taken together form a C4-C12 polymethylene chain, which is unsubstituted or substituted by C1-C12 alkyl, C2-C12 alkenyl or C1-C12 alkylidene; or pharmaceutically acceptable salt thereof; in the preparation of a medicament for use in the treatment of adult-T-cell leukemia-lymphoma, in particular brought on by infection with HTLV-I.
机译:式(I)的2,2'-bi-1H-吡咯的化合物的用途,其中R1是氢,苯基,C1-C20烷基或C2-C20烯基,其中烷基和烯基未被取代或被取代1-3个取代基; R2是氢,C1-C6烷基,氰基,羧基或(C1-C6烷氧基)羰基; R3是未被取代或被苯基取代的卤素,羟基或C1-C11烷氧基; R4代表氢,C1-C6烷基或苯基; R5和R6各自相同或不同,分别代表氢,C2-C20链烷酰基,C3-C20链烯酰基,苯基,C1-C20烷基或C2-C20链烯基,其中链烷酰基,链烯酰基,烷基和链烯基未取代或被1-3个取代基取代; R4,R5和R6中的两个一起形成C4-C12多亚甲基链,其未被取代或被C1-C12烷基,C2-C12烯基或C1-C12亚烷基取代。或其药学上可接受的盐;在制备用于治疗成人T细胞白血病淋巴瘤的药物中的用途,特别是由HTLV-1感染引起的。

著录项

相似文献

  • 专利
  • 外文文献
  • 中文文献
获取专利

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号